XENE
Xenon Pharmaceuticals Inc.Company with tickers: XENE
CIK
1582313
CUSIP
98420N105
Shares Outstanding
96,665,550
13F Activity (30d)
268 filings
267 filers
Price
$53.98
Market Cap
$5.22B
P/E Ratio
-12.38
EPS (Diluted)
$-4.36
52W High
$63.95
52W Low
$28.19
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $112,328,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $88,508,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-112,328,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-102,302,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-1.17 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-1.17 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |